The present invention relates to compositions and methods for the delivery of biologically-
relevant moieties to subjects in need thereof. Particles comprising a physically entrapped …

This disclosure relates to compositions for delivering agents to a subject, and in particular, to
compositions for delivery of therapeutic agents or diagnostic agents in the presence or …

0002 This invention relates to therapeutic and imaging agents which are comprised of a
targeting entity, a thera peutic or treatment entity and a linking carrier. In preferred agents of …

One aspect of the present invention relates to a synthetic non-viral vector composition for
gene therapy. Another aspect of the invention relates to the use of the composition for in …

Peptide-macromolecule complexes for delivery of nucleic acid to a cell. The nucleic acid
carrier includes a binding complex. The binding complex contains a binding moiety Which …

Peptide-macromolecule complexes for delivery of nucleic acid to a cell. The nucleic acid
carrier includes a binding complex. The binding complex contains a binding moiety which …

The invention relates to the targeted delivery of substances to cells. The invention provides a
virus-like particle or gene delivery vehicle provided with a ligand capable of binding to a …

(57) ABSTRACT A cell penetrating peptide which has following sequence: NYBXBXBNQX,
wherein B represents a basic amino acid, X represents an amino acid with an aromatic, a …

One aspect of the disclosure is to disclose a cell penetrating peptide Which comprises an
amino acid sequence of D” and 2sns1 5. Another aspect of the disclosure is to disclose a …

Disclosed are targeting constructs for targeting a target site, including a molecule or complex
of interest. The targeting constructs comprise a polymer chain and a plurality of multi-specific …